Non-alcoholic fatty liver disease (NAFLD)is associated with high cardiovascular morbidity and mortality which usually is considered to be related to cardiac involvement, while scarce attention is addressed to brain damage. Viceversa NAFLD is associated with asymptomatic brain lesions, alterations in cerebral perfusion and activity, cognitive impairment and brain aging and with increased risk and severity of both ischemic and haemorrhagic stroke. Besides known metabolic risk factors, NAFLD is characterized by a pro inflammatory state, which contributes to atherosclerosis and microglia activation, endothelial dysfunction, pro-coagulant state and platelets activation, which in turn promote both micro and macrovascular damage eventually responsible for clinical and subclinical cerebrovascular alterations. A better knowledge of the association between NAFLD and brain alterations could lead to an improved management of risk factors underpinning both liver and cerebral disease, possibly preventing the progression of asymptomatic brain lesions to clinical cerebrovascular accidents.

Brain involvement in non-alcoholic fatty liver disease (NAFLD) : a systematic review / R. Lombardi, S. Fargion, A.L. Fracanzani. - In: DIGESTIVE AND LIVER DISEASE. - ISSN 1590-8658. - 51:9(2019 Sep), pp. 1214-1222. [10.1016/j.dld.2019.05.015]

Brain involvement in non-alcoholic fatty liver disease (NAFLD) : a systematic review

R. Lombardi;S. Fargion;A.L. Fracanzani
2019

Abstract

Non-alcoholic fatty liver disease (NAFLD)is associated with high cardiovascular morbidity and mortality which usually is considered to be related to cardiac involvement, while scarce attention is addressed to brain damage. Viceversa NAFLD is associated with asymptomatic brain lesions, alterations in cerebral perfusion and activity, cognitive impairment and brain aging and with increased risk and severity of both ischemic and haemorrhagic stroke. Besides known metabolic risk factors, NAFLD is characterized by a pro inflammatory state, which contributes to atherosclerosis and microglia activation, endothelial dysfunction, pro-coagulant state and platelets activation, which in turn promote both micro and macrovascular damage eventually responsible for clinical and subclinical cerebrovascular alterations. A better knowledge of the association between NAFLD and brain alterations could lead to an improved management of risk factors underpinning both liver and cerebral disease, possibly preventing the progression of asymptomatic brain lesions to clinical cerebrovascular accidents.
Cognitive impairment; Liver steatosis; Neurological damage; Stroke disability
Settore MED/06 - Oncologia Medica
set-2019
Article (author)
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S1590865819305948-main.pdf

accesso riservato

Descrizione: Article in press
Tipologia: Publisher's version/PDF
Dimensione 1.07 MB
Formato Adobe PDF
1.07 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
main.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 1.05 MB
Formato Adobe PDF
1.05 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/675457
Citazioni
  • ???jsp.display-item.citation.pmc??? 18
  • Scopus 45
  • ???jsp.display-item.citation.isi??? 39
social impact